Welcome to Nutraceuticals World   
May 2013 Issue
Last Updated Thursday, May 23 2013
Print RSS Feed

Peer-Reviewed Research

Related Searches: soy

May 1, 2003
Indication: Blood pressure reduction Source: American Heart Association meeting Research: Sixty post-menopausal women were given a half cup of dry roasted soy nuts each day over a period of eight weeks. The purpose of the study was to assess th…  Read More »

May 1, 2003
Indication: Skin disorders Source: International Journal of Dermatology, 2002;41:146-150. Research: Researchers asked 96 patients with atopic dermatitis to take either 400 IU of natural-source vitamin E or placebos daily for eight months. Among…  Read More »

May 1, 2003
Indication: Blood pressure Source: International Journal for Vitamin & Nutrition Research, 2002;72:309-314. Research: Researchers asked 70 patients with newly diagnosed mild hypertension to take either 200 IU of vitamin E or placebos daily…  Read More »

May 1, 2003
Indication: Hip fractures Source: Am J Clin Nutr, 2002;77(2):512-516. Research: Investigators studied cross-sectional associations between self-reported dietary vitamin K intake and bone mineral density (BMD) of the hip and spine in men and wom…  Read More »

April 1, 2003
Indication: Back and joint pain Source: J Bone Miner Metab 2002;20(5)298-302. Research: The effect of active ab­sorb­able algal calcium (AAA Ca) with collagen and other matrix components on aging-associated skin changes and backache and…  Read More »

April 1, 2003
Indication: Preeclampsia Source: Am J Obst Gyn, 2002;187:777-784. Research: In this study, researchers analyzed changes in biochemical markers of preeclampsia, which doctors use to assess risk in pregnant women. These markers included blood lev…  Read More »

April 1, 2003
Indication: Migraine headaches Source: Cephalalgia, 2002;22:523-532. Research: Researchers treated 147 pa­tients with migraine headaches with either feverfew extract (2.08 mg, 6.25 mg or 18.75 mg) or a placebo three times daily for 12 weeks…  Read More »

April 1, 2003
Indication: Memory Source: Physiology & Behavior, 2002;75:739-751. Research: Researchers asked 20 men and women, with an average age of 21 years, to take the following single dosages during separate supplementation periods: 360 mg of ginkgo…  Read More »

April 1, 2003
Indication: Infection/quality of life Source: Annals of Internal Medicine, 2003;138:365-371. Research: In a randomized, double-blind, placebo-controlled trial, 130 community-dwelling adults stratified by age (45-65 years) and presence of type I…  Read More »

January 1, 2003
Indication: Heart disease Source: JAMA November, 2002;288:2432-2440. Research: The Women’s Angiographic Vitamin and Estrogen (WAVE) trial studied 423 women at seven clinical centers in the U.S. and Canada. The women were randomly assigned…  Read More »

January 1, 2003
Indication: LDL oxidation Source: Am J Clin Nutr December, 2002;76(6):1367-74. Research: Subjects were randomly assigned to receive either 400 IU RRR-alpha-tocopherol/d or 10 ml Concord grape juice (CGJ) for two weeks. Serum oxygen radical abso…  Read More »

January 1, 2003
Indication: Metabolism Source: Metabolism, 2002;51(11):1389-91. Research: The study investigated the effects of oral L-Carnipure® L-Carnitine Crystalline supplementation on in vivo long chain fatty acid oxidation by measuring 1-[13-C] palmi…  Read More »

January 1, 2003
Indication: Vision loss Source: Ophthalmology, 2002;109:1780-1787. Research: The study was based on the hypothesis that the levels of lutein in the eyes of people with age-related macular degeneration (AMD) would be lower than the levels of lu…  Read More »

January 1, 2003
Indication: Liver cancer Source: American Academy of Cancer Research Meeting, October 2002. Research: A five-year clinical study conducted in Japan examined liver cancer prevention in high risk liver cancer patients (hepatitis C virus carriers,…  Read More »

January 1, 2003
Indication: Cancer Source: 3rd Annual Meeting of the Japanese Society of Complementary & Alternative Medicine Research: Over 200 patients with a variety of terminal cancers were evaluated for 18 months. Patients were given MGN3, a patented…  Read More »

Receive free Nutraceuticals World emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Nutraceuticals World On